Literature DB >> 21988936

Intracrine and myotrophic roles of 5α-reductase and androgens: a review.

Joshua F Yarrow1, Sean C McCoy, Stephen E Borst.   

Abstract

UNLABELLED: Historically, the circulation was thought to be the primary source of androgens influencing skeletal muscle. However, a growing body of research indicates that skeletal muscle expresses several androgen-synthesizing enzymes, including 5α-reductase. The intramuscular expression of these enzymes suggests that skeletal muscle is capable of synthesizing bioactive androgens, which could induce myotrophic effects via intracrine action.
PURPOSE: The aim of this brief review is to discuss recent research related to the intracrine and myotrophic roles of androgens, with particular focus on 5α-reductase as a myotrophic mediator.
METHODS: Included in the review are 17 reviews and 58 original studies that were identified by a systematic review from MEDLINE and deemed particularly relevant to our purpose. Results are summarized to provide an overview of 5α-reductase as a mediator of the myotrophic effects of androgens. In particular, discussions are included regarding androgen biosynthesis and androgen signaling within skeletal muscle, the effects of exercise on intramuscular androgen biosynthesis, and clinical applications of androgens and of a new class of myotrophic agonists termed selective androgen receptor modulator.
RESULTS: The ability of several peripheral tissues to synthesize bioactive androgens is well documented in the literature. Herein, we summarize newer studies that demonstrate that 1) skeletal muscle has the capability to synthesize both testosterone and dihydrotestosterone from dehydroepiandrosterone, which is present in abundance within the circulation, and 2) that exercise increases the expression of certain androgen-biosynthesizing enzymes within muscle.
CONCLUSIONS: Intramuscularly synthesized androgens have the potential to influence skeletal muscle via intracrine action; however, their exact role in skeletal muscle development and maintenance requires further elucidation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21988936     DOI: 10.1249/MSS.0b013e31823bfcbf

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  15 in total

Review 1.  Review of health risks of low testosterone and testosterone administration.

Authors:  Huanguang Jia; Charles T Sullivan; Sean C McCoy; Joshua F Yarrow; Matthew Morrow; Stephen E Borst
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 2.  Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

Authors:  Stephen E Borst; Joshua F Yarrow
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

3.  Dihydrotestosterone (DHT) rapidly increase after maximal aerobic exercise in healthy males: the lowering effect of phosphodiesterase's type 5 inhibitors on DHT response to exercise-related stress.

Authors:  P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2020-09-18       Impact factor: 4.256

Review 4.  Sport and male sexuality.

Authors:  P Sgrò; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2017-03-22       Impact factor: 4.256

5.  Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

Authors:  Stephen E Borst; Joshua F Yarrow; Christine F Conover; Unyime Nseyo; John R Meuleman; Judyta A Lipinska; Randy W Braith; Darren T Beck; Jeffrey S Martin; Matthew Morrow; Shirley Roessner; Luke A Beggs; Sean C McCoy; Darryl F Cannady; Jonathan J Shuster
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

6.  Testosterone responses to standardized short-term sub-maximal and maximal endurance exercises: issues on the dynamic adaptive role of the hypothalamic-pituitary-testicular axis.

Authors:  P Sgrò; F Romanelli; F Felici; M Sansone; S Bianchini; C F Buzzachera; C Baldari; L Guidetti; F Pigozzi; A Lenzi; L Di Luigi
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

7.  Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone.

Authors:  Luke A Beggs; Joshua F Yarrow; Christine F Conover; John R Meuleman; Darren T Beck; Matthew Morrow; Baiming Zou; Jonathan J Shuster; Stephen E Borst
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-07-29       Impact factor: 4.310

8.  Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury.

Authors:  Joshua F Yarrow; Christine F Conover; Luke A Beggs; Darren T Beck; Dana M Otzel; Alexander Balaez; Sarah M Combs; Julie R Miller; Fan Ye; J Ignacio Aguirre; Kathleen G Neuville; Alyssa A Williams; Bryan P Conrad; Chris M Gregory; Thomas J Wronski; Prodip K Bose; Stephen E Borst
Journal:  J Neurotrauma       Date:  2014-05-01       Impact factor: 5.269

Review 9.  Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.

Authors:  Stephen E Borst; Jonathan J Shuster; Baiming Zou; Fan Ye; Huanguang Jia; Anita Wokhlu; Joshua F Yarrow
Journal:  BMC Med       Date:  2014-11-27       Impact factor: 8.775

10.  Influence of androgens on circulating adiponectin in male and female rodents.

Authors:  Joshua F Yarrow; Luke A Beggs; Christine F Conover; Sean C McCoy; Darren T Beck; Stephen E Borst
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.